Literature DB >> 23781658

Comparison of essential drug list in a rural secondary care hospital in south India with Indian & World Health Organization list 2011.

Seetharama G Rao1, Dixon Thomas, Seeba Zachariah, M S Kannan, Gerardo Alvarez-Uria.   

Abstract

OBJECTIVE: Fixed drug combinations are a major marketing strategy in India but it can compromise the rational use of medicines. In this study we compared the fixed drug combinations and dosage forms in the hospital pharmacy before and after introducing the essential drug list. We also compared the Hospital Essential Drug List (HEDL) 2011 with the World Health Organization (WHO) Essential Drug List (EDL) 2011 and the National Essential Drug List of India (NEDL) 2011.
METHODS: The study was done in a secondary level care charity hospital at Anantapur, AP with a bed size of 315 and an average OP per day of 1200-1700 visits. We compared the three essential drug lists (HEDL, WHOEDL and NEDL) and the hospital drug list before introducing EDL. Drugs which were present in NEDL and not present in the HEDL were also screened. Microsoft excel was used to tabulate the results and for graphs.
RESULTS: The number of medicines used in the hospital before and after the introduction of the HEDL was 1627 and 424 respectively. On comparison, WHOEDL 2011 have 350 and NEDL of India have 348 medicines. While preparing the HEDL, 46 double drug combinations decreased to 15 and 9 triple drug combinations decreased to 1. In the case of injections, 20 double drug combinations decreased to 6 and 1 triple drug combination increased to 2. The number of tablets, capsules, injections, syrups, powders and inhalers was reduced to almost half. The great reductions were in 51 ointments to 9, 69 drops to 5, 11 paste to 0, 21 solutions to 3 and 14 creams to 1. The dosage forms removed included elixirs, insulin pens, gums, paste, paints, gargles and mouthwashes.
CONCLUSIONS: There was drastic reduction in the number of medicines and dosage forms when the HEDL was implemented. Many of the fixed drug combinations were also removed for improving the rational use of medicines. The WHO essential drug list 2011, national essential drug list of India 2011 and the hospital essential drug list 2011 were comparable with few exceptions.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 23781658

Source DB:  PubMed          Journal:  Indian J Physiol Pharmacol        ISSN: 0019-5499


  2 in total

Review 1.  Essential drugs production in Brazil, Russia, India, China and South Africa (BRICS): opportunities and challenges.

Authors:  Zoheir Ezziane
Journal:  Int J Health Policy Manag       Date:  2014-11-06

2.  Cost-analysis of the WHO Essential Medicines List in A Resource-Limited Setting: Experience from A District Hospital in India.

Authors:  Gerardo Alvarez-Uria; Dixon Thomas; Seeba Zachariah; Rajarajeshwari Byram; Shanmugamari Kannan
Journal:  J Clin Diagn Res       Date:  2014-05-15
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.